RBC Capital analyst Charles Weston maintained a Buy rating on Evotec (0IRF – Research Report) today and set a price target of €11.60. The company’s shares closed yesterday at €9.83.
RBC Capital analyst Charles Weston maintained a Buy rating on Evotec (0IRF – Research Report) today and set a price target of €11.60. The company’s shares closed yesterday at €9.83.
Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1. STOCK NEWS: Amazon (AMZN) will invest an additional $4B in Anthropic
Evotec (EVO) issued the following comment on the withdrawn non-binding offer: “Evotec SE has taken notice of the statement made by Halozyme (HALO) Therapeutics Inc. on 22 November, stating that
בינתיים, מניית Halozyme עלתה ב-11% ל-50.99 דולר במסחר המוקדם.
Halozyme (HALO) is up 11% to $50.99 in pre-market trading. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’ Hot Stocks